Perrigo Company Plc Stock Performance
PRGO Stock | USD 27.29 0.30 1.09% |
The company holds a Beta of 1.4, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Perrigo Company will likely underperform. Perrigo Company right now holds a risk of 1.84%. Please check Perrigo Company potential upside, as well as the relationship between the kurtosis and day typical price , to decide if Perrigo Company will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Perrigo Company PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Perrigo Company is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (1.09) | Five Day Return (4.11) | Year To Date Return (17.73) | Ten Year Return (82.21) | All Time Return 134.65 |
Forward Dividend Yield 0.0405 | Payout Ratio 0.4434 | Last Split Factor 2:1 | Forward Dividend Rate 1.1 | Dividend Date 2024-12-17 |
Perrigo Company dividend paid on 17th of September 2024 | 09/17/2024 |
1 | Is Alibaba Group Holding Limited the Best Growth Stock To Buy According To George Soros | 09/24/2024 |
2 | Insider Trading | 10/01/2024 |
3 | Disposition of 1641 shares by Schmelter Triona of Perrigo Company subject to Rule 16b-3 | 10/04/2024 |
4 | WNBA Star Napheesa Collier Joins Team Opill for Candid Conversations on Womens Health | 10/15/2024 |
5 | Acquisition by Erica Mann of 8764 shares of Perrigo Company at 30.22 subject to Rule 16b-3 | 10/25/2024 |
6 | Perrigo declares 0.276 dividend | 11/01/2024 |
7 | Perrigo reaffirms full-year outlook despite Q3 earnings, revenue miss | 11/06/2024 |
8 | Perrigo Co PLC Q3 2024 Earnings Call Highlights Strategic Savings and EPS Growth Amid ... | 11/07/2024 |
9 | Perrigo Third Quarter 2024 Earnings US0.13 loss per share | 11/08/2024 |
10 | Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update | 11/12/2024 |
11 | Acquisition by Robert Willis of 1759 shares of Perrigo Company at 28.09 subject to Rule 16b-3 | 11/15/2024 |
12 | Perrigo Company plc Shares Sold by Thompson Siegel Walmsley LLC - MarketBeat | 11/21/2024 |
13 | Acquisition by Adriana Karaboutis of 8764 shares of Perrigo Company at 30.22 subject to Rule 16b-3 | 11/22/2024 |
14 | Candel therapeutics chief medical officer sells 63,482 in stock | 12/03/2024 |
15 | Perrigo Up 5.6 percent Since Last Earnings Report Can It Continue | 12/06/2024 |
16 | Disposition of 17598 shares by Jeffrey Kindler of Perrigo Company at 28.27 subject to Rule 16b-3 | 12/09/2024 |
17 | Most women in the US arent accessing family planning services, even as abortion restrictions grow | 12/11/2024 |
Begin Period Cash Flow | 600.7 M |
Perrigo |
Perrigo Company Relative Risk vs. Return Landscape
If you would invest 2,748 in Perrigo Company PLC on September 13, 2024 and sell it today you would lose (19.00) from holding Perrigo Company PLC or give up 0.69% of portfolio value over 90 days. Perrigo Company PLC is currently generating 0.0054% in daily expected returns and assumes 1.8374% risk (volatility on return distribution) over the 90 days horizon. In different words, 16% of stocks are less volatile than Perrigo, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Perrigo Company Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Perrigo Company's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Perrigo Company PLC, and traders can use it to determine the average amount a Perrigo Company's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0029
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | PRGO |
Estimated Market Risk
1.84 actual daily | 16 84% of assets are more volatile |
Expected Return
0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Perrigo Company is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Perrigo Company by adding Perrigo Company to a well-diversified portfolio.
Perrigo Company Fundamentals Growth
Perrigo Stock prices reflect investors' perceptions of the future prospects and financial health of Perrigo Company, and Perrigo Company fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Perrigo Stock performance.
Return On Equity | -0.0316 | ||||
Return On Asset | 0.0137 | ||||
Profit Margin | (0.04) % | ||||
Operating Margin | 0.10 % | ||||
Current Valuation | 7.01 B | ||||
Shares Outstanding | 136.43 M | ||||
Price To Earning | 23.57 X | ||||
Price To Book | 0.82 X | ||||
Price To Sales | 0.85 X | ||||
Revenue | 4.66 B | ||||
Gross Profit | 1.46 B | ||||
EBITDA | 575.9 M | ||||
Net Income | (12.7 M) | ||||
Cash And Equivalents | 490.4 M | ||||
Cash Per Share | 3.64 X | ||||
Total Debt | 4.07 B | ||||
Debt To Equity | 0.89 % | ||||
Current Ratio | 2.61 X | ||||
Book Value Per Share | 33.45 X | ||||
Cash Flow From Operations | 405.5 M | ||||
Earnings Per Share | (1.07) X | ||||
Market Capitalization | 3.72 B | ||||
Total Asset | 10.81 B | ||||
Retained Earnings | (2.08 B) | ||||
Working Capital | 1.25 B | ||||
Current Asset | 3.18 B | ||||
Current Liabilities | 1.69 B | ||||
About Perrigo Company Performance
By examining Perrigo Company's fundamental ratios, stakeholders can obtain critical insights into Perrigo Company's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Perrigo Company is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 139.97 | 88.17 | |
Return On Capital Employed | 0.02 | 0.02 |
Things to note about Perrigo Company performance evaluation
Checking the ongoing alerts about Perrigo Company for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Perrigo Company help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.The company reported the previous year's revenue of 4.66 B. Net Loss for the year was (12.7 M) with profit before overhead, payroll, taxes, and interest of 1.46 B. | |
Latest headline from cnn.com: Most women in the US arent accessing family planning services, even as abortion restrictions grow |
- Analyzing Perrigo Company's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Perrigo Company's stock is overvalued or undervalued compared to its peers.
- Examining Perrigo Company's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Perrigo Company's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Perrigo Company's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Perrigo Company's stock. These opinions can provide insight into Perrigo Company's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Perrigo Company PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Perrigo Company. If investors know Perrigo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Perrigo Company listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.64) | Dividend Share 1.101 | Earnings Share (1.07) | Revenue Per Share 32.088 | Quarterly Revenue Growth (0.03) |
The market value of Perrigo Company is measured differently than its book value, which is the value of Perrigo that is recorded on the company's balance sheet. Investors also form their own opinion of Perrigo Company's value that differs from its market value or its book value, called intrinsic value, which is Perrigo Company's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Perrigo Company's market value can be influenced by many factors that don't directly affect Perrigo Company's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Perrigo Company's value and its price as these two are different measures arrived at by different means. Investors typically determine if Perrigo Company is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Perrigo Company's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.